1Balen AH,Conmwy GS,Homburg R, el al. Polycystic ovary syndrome [ M ]. United Kingdom : Taylor & Francis Press, 2005:59 - 64.
2Balen AH. Paediatric and adolecent gynaecology [ M I. United Kingdom:Cambridge University Press,2004 : 342-353.
3Speroff L,Fritz MA. Clinical gynecological endocrinology and infertility[M]. United States of Ameriea:Uppinneott Williams and Wilkins ,2005:465-498.
4van Hooff MH, Voorhorst FJ, Kaptein MB, et al. Endocrine features of PCOS in a random population sample of 14-16 year old adolescents [ J ]. Hum Reprod, 1999 , 14 ( 9 ) : 2223-2229.
5Li L, Yang DZ, Chen XL. Clinical and metabolism features of PCOS [ J ]. Int J Obstet Gynecol, 2007, 97 (2) : 129-134.
6Harwood K. Current approaches to the diagnosis and treatment of PCOS in youth[ J]. Horm Res, 2007,68:209-217.
7Ibanez L, Vails C, Marcos MV, et ai. Insulin sensitization for girls with precocious pubarche and with risk for PCOS: effects of prepubertai initiation and postpubertal discontinuatiuon of met- formin treatment [ J ]. J Clin Endocrinol Metab, 2004 , 89 ( 9 ) : 4331-4337.
8Salmi DJ, Zisser HC, Jovanovic L. Sceening for and treatment of PCOS in teenager [ J ]. Exp Biol Med, 2004,229,369-377.
1Pantanetti P, Garrapa GG, Mantero F, et al. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens,2004,26:387-398.
2Diamanti-Kandarakis E, BergieleA. The influence of obesity on hyperandrogenism and infertility in the female. Obesity Reviews ,2001, 2:231-238.
3Ciampelli M , Leoni F , Lattanzi F , et al. A pilot study of the long 2 term effects of acipimox in polycystic ovarian syndrome. Hum Reprod, 2002 ,17:647-653.
4Marsden PJ , Murdoch AP , Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol , 2001 ,55:191-199.
5Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev, 1997,18 : 774 - 800.
6Barzilai N, Wang J, Massilon D, et al. Leptin selesctively decreases visceral adiposity and enhances insulin action. J Clin Invest, 1997,100:3105-3110.
7Farah L, Lazenby A J, Boots LR, et al. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists(Alabama Professional Electrology Association Study Group ). J Reprod Med, 1999,44:870-974.
8Diamanti-Kandarakis E, Kouli CR, Bergiele AT ,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbost hormonal and metabolic profile. J Clin Endocrinol Metab, 1999, 84: 4006-4011.
9Gambineril A, Pelusil C, Vicennatil V, et al. Obesity and the polycystic ovary syndrome. Int J Obesity, 2002,26:883-896.
10Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol, 1993,39: 1-16.
